Showing results (201-210 of 427) with videos related to

Sort By:
Pageof 43
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastasesPatrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Psycho-Oncology|February 11, 2000
A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partnersJ M Donnelly, A B Kornblith, S Fleishman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2013
Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancerPatrick G Morris, Xi Kathy Zhou, Ginger L Milne, et al.
The Oncologist|March 18, 2016
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast CancerAnthony F Yu, Carlos Manrique, Shawn Pun, et al.
Psychosomatic Medicine|November 1, 1992
An experimental analysis of classically conditioned nausea during cancer chemotherapyD H Bovbjerg, W H Redd, P B Jacobsen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
International Journal of Obesity (2005)|November 7, 2017
Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer linkH Zahid, K Subbaramaiah, N M Iyengar, et al.
Clinical Breast Cancer|August 14, 2010
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancerAlison K Conlin, Andrew D Seidman, Ariadne Bach, et al.
Cancer|June 22, 2010
Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicityMariana Chavez-Macgregor, Jennifer Litton, Huiqin Chen, et al.
Pageof 43